Joel Michalski

1.0k total citations
30 papers, 810 citations indexed

About

Joel Michalski is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Joel Michalski has authored 30 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Joel Michalski's work include Phosphodiesterase function and regulation (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Joel Michalski is often cited by papers focused on Phosphodiesterase function and regulation (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Joel Michalski collaborates with scholars based in United States, Japan and Germany. Joel Michalski's co-authors include James B. Kaper, Stephen I. Rennard, Michele Trucksis, Alessio Fasano, James E. Galen, Amy Nelson, Xiangde Liu, Xingqi Wang, Masanori Nakanishi and Nobuhiro Kanaji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Joel Michalski

30 papers receiving 791 citations

Peers

Countries citing papers authored by Joel Michalski

Since Specialization

Citations

This map shows the geographic impact of Joel Michalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Michalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Michalski more than expected).

Fields of papers citing papers by Joel Michalski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Michalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Michalski. The network helps show where Joel Michalski may publish in the future.

Co-authorship network of co-authors of Joel Michalski

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Michalski. A scholar is included among the top collaborators of Joel Michalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Michalski. Joel Michalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation. 2024 ·Journal of Clinical Oncology ·Judy S. Wang, David Sommerhalder, Manish Sharma, William J. Edenfield, Kartik Sehgal, Do‐Youn Oh, Yixing Jiang, Joel Michalski, Jeeyun Lee, Hans J. Hammers, Li‐Yuan Bai, Chih‐Hung Hsu, (unknown), Kefei Zhou, Lisa K. Blum, (unknown), (unknown), Hsiao D. Lieu, Vladimir Hanes, Aung Naing	2
2	MYTX-011 in patients with previously treated locally advanced or metastatic NSCLC: Initial dose escalation results in the phase 1 KisMET-01 study. 2024 ·Journal of Clinical Oncology ·Melissa L. Johnson, Timothy F. Burns, Jonathan R. Thompson, Alexander I. Spira, Mariam P. Alexander, George R. Blumenschein, Joel Michalski, Sanela Bilic, (unknown), Katharine C. Lai, (unknown), (unknown), (unknown), Tinghui Wu, Gilles Gallant, Rebecca S. Heist	2
3	Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002 2023 ·The Oncologist ·Robert J. Motzer, Toni K. Choueiri, Benjamin Garmezy, Bert H. O’Neil, Joel Michalski, Pedro C. Barata, (unknown), Jad Chahoud, Mohan Liu, Fiona Xu, (unknown), Neil J. Shah, Bradley A. McGregor	2
4	Thrombotic Thrombocytopenic Purpura 2021 ·StatPearls ·Michael Stanley, (unknown), Joel Michalski	1
5	Thrombotic Thrombocytopenic Purpura (TTP) 2019 ·StatPearls ·Michael Stanley, Joel Michalski	3
6	Agonist-specific desensitization of PGE2-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts 2019 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), Nancy A. Schulte, (unknown), Joel Michalski, Stephen I. Rennard, Raymond B. Penn, Myron L. Toews, Rennolds S. Ostrom	10
7	Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Prajwal Dhakal, Elizabeth Lyden, (unknown), Joel Michalski, Zaid Al‐Kadhimi, Lori J. Maness, Krishna Gundabolu, Vijaya Raj Bhatt	11
8	Evaluation of a Novel Handoff Communication Strategy for Patients Admitted from the Emergency Department 2018 ·Western Journal of Emergency Medicine ·Christopher J. Smith, (unknown), (unknown), Joel Michalski, (unknown), (unknown), (unknown)	30
9	Phosphodiesterase-4 Inhibition Augments Human Lung Fibroblast Vascular Endothelial Growth Factor Production Induced by Prostaglandin E2 2013 ·American Journal of Respiratory Cell and Molecular Biology ·Jun Ikari, Joel Michalski, Shunichiro Iwasawa, (unknown), (unknown), Joo Hun Park, Amy Nelson, Maha Farid, Xingqi Wang, Nancy A. Schulte, Hesham Basma, Myron L. Toews, Carol Feghali‐Bostwick, Hermann Tenor, Xiangde Liu, Stephen I. Rennard	11
10	Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts 2013 ·Toxicology Letters ·Maha Farid, Nobuhiro Kanaji, Masanori Nakanishi, (unknown), Joel Michalski, Shunichiro Iwasawa, Jun Ikari, Xingqi Wang, Hesham Basma, Amy Nelson, Xiangde Liu, Stephen I. Rennard	21
11	Attenuation of Inhibitory Prostaglandin E2 Signaling in Human Lung Fibroblasts Is Mediated by Phosphodiesterase 4 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Joel Michalski, Nobuhiro Kanaji, Xiangde Liu, (unknown), Xingqi Wang, Hesham Basma, Masanori Nakanishi, Tadashi Sato, (unknown), (unknown), Amy Nelson, (unknown), Olaf Holz, H Magnussen, Klaus F. Rabe, Myron L. Toews, Stephen I. Rennard	10
12	Differential Roles of JNK, ERK1/2, and p38 Mitogen-Activated Protein Kinases on Endothelial Cell Tissue Repair Functions in Response to Tumor Necrosis Factor-α 2012 ·Journal of Vascular Research ·Nobuhiro Kanaji, Amy Nelson, Xingqi Wang, Tadashi Sato, Masanori Nakanishi, (unknown), Hesham Basma, Joel Michalski, Maha Farid, Stephen I. Rennard, Xiangde Liu	18
13	Prostaglandin E2 Stimulates the Production of Vascular Endothelial Growth Factor through the E-Prostanoid–2 Receptor in Cultured Human Lung Fibroblasts 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Masanori Nakanishi, Tadashi Sato, (unknown), Amy Nelson, Maha Farid, Joel Michalski, Nobuhiro Kanaji, Xingqi Wang, Hesham Basma, Amol Patil, (unknown), Xiangde Liu, Shinsaku Togo, Myron L. Toews, Olaf Holz, (unknown), H Magnussen, Stephen I. Rennard	22
14	Prostaglandin E2 signaling in human lung fibroblasts: mechanisms of signal attenuation and implications in chronic lung diseases 2011 ·Graduate Medical Education Research Journal ·Joel Michalski	1
15	PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease 2011 ·Clinical Pharmacology & Therapeutics ·Joel Michalski, (unknown), Jun Ikari, Stephen I. Rennard	65
16	IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells 2011 ·Journal of Allergy and Clinical Immunology ·Tadashi Sato, Xiangde Liu, Hesham Basma, Shinsaku Togo, Hisatoshi Sugiura, Amy Nelson, Masanori Nakanishi, Nobuhiro Kanaji, Xingqi Wang, Mi‐Ok Kim, Yingji Li, Joel Michalski, Maha Farid, John Sharp, Stephen I. Rennard	8
17	The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair 2011 ·Inflammation Research ·Nobuhiro Kanaji, Amy Nelson, Diane Allen‐Gipson, Tadashi Sato, Masanori Nakanishi, Xingqi Wang, Yingji Li, Hesham Basma, Joel Michalski, Maha Farid, Stephen I. Rennard, Xiangde Liu	11
18	Reduced miR-146a Increases Prostaglandin E2 in Chronic Obstructive Pulmonary Disease Fibroblasts 2010 ·American Journal of Respiratory and Critical Care Medicine ·Tadashi Sato, Xiangde Liu, Amy Nelson, Masanori Nakanishi, Nobuhiro Kanaji, Xingqi Wang, Mi‐Ok Kim, Yingji Li, Jianhong Sun, Joel Michalski, Amol Patil, Hesham Basma, Olaf Holz, H Magnussen, Stephen I. Rennard	159
19	Prostaglandin E2 Inhibits Human Lung Fibroblast Chemotaxis through Disparate Actions on Different E-Prostanoid Receptors 2010 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Xingqi Wang, Tadashi Sato, Nobuhiro Kanaji, Masanori Nakanishi, Mi‐Ok Kim, Joel Michalski, Amy Nelson, (unknown), Maha Farid, Hesham Basma, Amol Patil, Myron L. Toews, Xiangde Liu, Stephen I. Rennard	24
20	MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis 2009 ·Biochemical and Biophysical Research Communications ·Xiangde Liu, Amy Nelson, Xingqi Wang, Nobuhiro Kanaji, Mi‐Ok Kim, Tadashi Sato, Masanori Nakanishi, (unknown), (unknown), Joel Michalski, Amol Patil, Hesham Basma, Stephen I. Rennard	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact